Published Dec 10, 2021

Labshares Newton Doubles Space for Emerging Biotech Startups

Labshares News
Copy The Link to the  Article
Labshares Newton Doubles Space for Emerging Biotech Startups
Copy The Link to the  Article

Related or similar articles

View more News
August 8, 2018

Harbour BioMed inks $350 million deal for rights to A167

USA-based Harbour BioMed has entered into an exclusive strategic partnership with China’s Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize A167
Member News
June 13, 2024

Advancing Science at Labshares: Diagonal Therapeutics' Journey

Labshares News
March 13, 2019

Labshares Newton Grows its Business​

Labshares is unveiling a major rennovation
Labshares News